Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

Files
theoncologist_15182.pdf (678.41 KB)
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2015-09
Authors
Lourdes, Laura S.
Jalal, Shadia I.
Hanna, Nasser
Language
American English
Embargo Lift Date
Department
Department of Medicine, IU School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Alphamed Press
Abstract
Description
Keywords
afatinib, cisplatin, docetaxel, epidermal growth factor receptor kinase inhibitor, erlotinib, etoposide, gefitinib, protein tyrosine kinase, protein tyrosine kinase inhibitor, Chemotherapy, Radiotherapy
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Lourdes, L. S., Jalal, S. I., & Hanna, N. (2015). Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer. The Oncologist, 20(9), 975–978. http://doi.org/10.1634/theoncologist.2015-0182
ISSN
1549-490X
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Oncologist
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/10043
DOI
https://doi.org/10.1634/theoncologist.2015-0182
Version
Final published version
Full Text Available at
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571806/
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works